English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The aim of these guidelines is to minimize the risk of bleeding and thromboembolic complications in the periprocedural period of an endoscopic procedure. It is therefore reasonable to divide patients into groups at low, moderate, and high risk of thromboembolism (TE) (Table 1), and endoscopic procedures into groups carrying a low or high bleeding risk (Table 3). Generally, as the risk of TE increases, it is critical to minimize or discontinue anticoagulation therapy for a period as short as possible. On the other hand, with increasing risk of procedure-related bleeding, it is critical to extend the period a r t i c l e i n f o

Expert consensus statement for periprocedural anticoagulation and antiplatelet therapy in elective bronchoscopy